TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Sibo Jiang, Ph.D.
Manager, Process Development at Nitto Denko Avecia

Profile

Sibo Jiang joined the process development team at Nitto Denko Avecia in 2014. He is currently Manager of Process Development at the Avecia Cincinnati site, where together with his team, he is responsible for the development, transfer, optimization, validation of oligonucleotide API manufacturing processes to support from pre-clinical to late-phase programs. Sibo also contributed to the development, implementation and continuous improvement of Avecia’s OligGO oligonucleotide manufacturing technology platform. Sibo holds a Ph.D. in nucleic acid chemistry from the Georgia State University, Atlanta with a strong focus on the synthesis and structure study of chemically modified nucleic acids.

Sibo Jiang, Ph.D.'s Network

Agenda Sessions

  • Challenges Associated with Evolvement of Oligonucleotides Process Technology - From a CMO’s Perspective

    , 17:00